Wonseok Kang

17PUBLICATIONS
75CO-AUTHORS
Epidemiological modellingPredictive and prognostic markersMedical biochemistry - lipidsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 22, 2026
Metabolic Dysfunction-Associated Fibrosis 5 Score and the Risk of Liver-Related Events in the General Population.

|Feb 11, 2025
Assessing the Validity of the AASLD Surgical Treatment Algorithm in Patients with Early-Stage Hepatocellular Carcinoma.

Aryoung Kim, Byeong Geun Song, Wonseok Kang

|Nov 22, 2024
Serum Ferritin Levels and Liver-Related Events in Individuals With Steatotic Liver Disease: A Longitudinal Cohort Study.

Byeong Geun Song, Myung Ji Goh, Wonseok Kang

|Sep 25, 2024
Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing study.

Wonseok Kang, Yoon Jun Kim, Seung Up Kim

|Aug 10, 2024
Glycemic Burden and Clinical Outcomes of Early Stage Hepatocellular Carcinoma after Curative Treatment.

Hyun Joo Lee, Moon Seok Choi, Byeong Geun Song

|Jun 27, 2024
Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma.

Byeong Geun Song, Myung Ji Goh, Wonseok Kang

Pageof 3

Frequent Collaborators

10 joint publications

Dong Hyun Sinn

10 joint publications

Yong-Han Paik

10 joint publications

Geum-Youn Gwak

9 joint publications

Joon Hyeok Lee